Cuprotosis, a newly identified form of regulated cell death, has emerged as a potential therapeutic target for cancers.
Kidney renal clear cell carcinoma (KIRC) is frequently metastatic at diagnosis, resulting in poor prognosis.
This study aimed to identify prognostic biomarkers and construct a risk model to improve survival prediction and guide therapeutic strategies for KIRC patients.
